Biblio

Filters: First Letter Of Title is C [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C

LeBlanc R, Hollmann S, Tay J. Canadian cost analysis comparing maintenance therapy with bortezomib versus lenalidomide for patients with multiple myeloma post autologous stem cell transplant. J Popul Ther Clin Pharmacol. 2016;23(1):e103-e113.

Lin Y, Nan J, Shen J, Lv X, Chen X, Lu X, Zhang C, Xiang P, Wang Z, Li Z. Canagliflozin impairs blood reperfusion of ischaemic lower limb partially by inhibiting the retention and paracrine function of bone marrow derived mesenchymal stem cells. EBioMedicine. 2020;52:102637.

Sinha S, Bose C, Das U, Kuilya TKumar, Mondal J, Bhadra J, Banerjee P, Goswami RKumar. Cananginone Abrogates EMT in Breast Cancer Cells through Hedgehog Signaling. Chem Biodivers. 2022.

Uthamacumaran A. Cancer: A turbulence problem. Neoplasia. 2020;22(12):759-769.

Leyfman Y, Emmanuel N, Menon GP, Joshi M, Wilkerson WB, Cappelli J, Erick TK, Park CH, Sharma P. Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients. J Hematol Oncol. 2023;16(1):39.

Salimifard S, Masjedi A, Hojjat-Farsangi M, Ghalamfarsa G, Irandoust M, Azizi G, Mohammadi H, Keramati MReza, Jadidi-Niaragh F. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathol Res Pract. 2020:152915.

Fisher ML, Balinth S, Hwangbo Y, Wu C, Ballon C, Goldberg GL, Mills AA. Cancer associated fibroblasts promote cancer stemness by inducing expression of the chromatin modifying protein CBX4 in squamous cell carcinoma. Carcinogenesis. 2023.

Trama A, Stark D, Bozovic-Spasojevic I, Gaspar N, Peccatori F, Toss A, Bernasconi A, Quarello P, Scheinemann K, Jezdic S, et al. Cancer burden in adolescents and young adults in Europe. ESMO Open. 2023;8(1):100744.

Maleki EH, Bahrami AReza, Matin MM. Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance. Genes Dis. 2024;11(1):189-204.

Noubissi FK, Ogle BM. Cancer Cell Fusion: Mechanisms Slowly Unravel. Int J Mol Sci. 2016;17(9).

Tang D, Kondo T. Cancer Cell Heterogeneity and Plasticity: From Molecular Understanding to Therapeutic Targeting. Semin Cancer Biol. 2021.

Bhat GRasool, Sethi I, Sadida HQ, Rah B, Mir R, Algehainy N, Albalawi IAltedlawi, Masoodi T, Subbaraj GKumar, Jamal F, et al. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. Cancer Metastasis Rev. 2024.

da Silva-Diz V, Lorenzo-Sanz L, Bernat-Peguera A, Lopez-Cerda M, Muñoz P. Cancer cell plasticity: Impact on tumor progression and therapy response. Semin Cancer Biol. 2018.

Fatma H, Siddique HR. Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked?. Cancer Metastasis Rev. 2023.

Kurayoshi K, Ozono E, Iwanaga R, Bradford AP, Komori H, Ohtani K. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs. Biochem Biophys Res Commun. 2014.

Zou Y, Sun Y, Wang Y, Zhang D, Yang H, Wang X, Zheng M, Shi B. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment. Nat Commun. 2023;14(1):4557.

Movahed ZGhanbari, Rastegari-Pouyani M, Mohammadi MHossein, Mansouri K. Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?. Biomed Pharmacother. 2019;112:108690.

Pellicano F, Mukherjee L, Holyoake TLaurie. Cancer cells escape from oncogene addiction: Understanding the mechanisms behind treatment failure for more effective targeting. Stem Cells. 2014.

Little RB, Snowton M, Uziel O. Cancer cells possess different isotopic enrichment: Isotopic induced functionalizations of normal DNA mutations leading to cancer. Heliyon. 2024;10(1):e23519.

Rabiee S, Hoveizi E, Barati M, Salehzadeh A, Joghataei MTaghi, Tavakol S. Cancer cells same as zombies reprogram normal cells via the secreted microenvironment. PLoS One. 2023;18(7):e0288003.

Prasad S, Ramachandran S, Gupta N, Kaushik I, Srivastava SK. Cancer cells stemness: A doorstep to targeted therapy. Biochim Biophys Acta Mol Basis Dis. 2019.

Lamprecht S, Fich A. The cancer cells-of-origin in the gastrointestinal tract: progenitors revisited. Carcinogenesis. 2015.

Pang EM, Saynina O, Schapira L, Wise PH, Boynton H, Smith M, Chamberlain LJ, Smith SM. Cancer center-based follow-up among pediatric and adolescent/young adult cancer survivors: the role of a community-based organization and the social determinants of health. J Cancer Surviv. 2023.

Adil M, Kanwal S, Rasheed S, Iqbal M, Abbas G. Cancer Chemoresistance; Recent Challenges and Future Considerations. Cancer Treat Res. 2023;185:237-253.

Davodabadi F, Sajjadi SFatemeh, Sarhadi M, Mirghasemi S, Hezaveh MNadali, Khosravi S, Andani MKamali, Cordani M, Basiri M, Ghavami S. Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery. Eur J Pharmacol. 2023:176013.

Pages